When gene manipulating approaches were replaced by chemical agonist, Ou et al. 17 proved a beneficial role of GPR40 agonist GW9508 in hepatic steatosis in high fat diet-fed mice and oleic acid-induced lipid accumulation in HepG2 cells through a p38-dependent pathway. Here, FFAR1 is linked to fatty liver disease.